Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Search
About
Advertise
Advisory Board
Contact Us
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Conference Coverage
Conference Coverage
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Combination of Targeted Therapies Improves Survival in Advanced Colorectal Cancers
Danielle Garcia
-
July 6, 2019
Acalabrutinib Significantly Improves Progression-Free Survival in Chronic Lymphocytic Leukemia
RC48-ADC Shows Clinically Meaningful Results in Advanced HER2+ Urothelial Cancer
Majority of Gynecologic Oncologists have Experienced Sexual Harassment
Changing Clinical Trial Enrollment Criteria Dramatically Increases Participation of Eligible Patients with Lung Cancer
Brentuximab Vedotin Continues to Demonstrate Superior Clinical Activity
Peter Hofland, Ph.D
-
June 4, 2019
Laparoscopic Surgery vs. Open Surgery in Patients with Colorectal Cancer with...
Peter Hofland, Ph.D
-
June 4, 2019
Enfortumab Vedotin Produces a High Tumor Response Rate in Patients with...
Peter Hofland, Ph.D
-
June 3, 2019
Sub-population Analysis Shows High Rates of Durable Response and Overall Survival...
Peter Hofland, Ph.D
-
June 3, 2019
Phase I ZUMA-3 Results for KTE-X19 in ALL Show High Rates...
Peter Hofland, Ph.D
-
June 1, 2019
Liquid Biopsy Platform Demonstrates High Diagnostic Capabilities In Early Stages of...
Peter Hofland, Ph.D
-
May 31, 2019
Growing Importance of Community Oncologists in Clinical Research Evidenced by Large...
Peter Hofland, Ph.D
-
May 31, 2019
Study Shows Differences in the Prevalence of Breast Cancer Genes among...
Danielle Garcia
-
May 30, 2019
New Data From ZUMA Trials Offer Greater Understanding of CAR T-cell...
Peter Hofland, Ph.D
-
May 28, 2019
Findings from Two TAPUR? Study Cohorts to be Presented at 2019...
Peter Hofland, Ph.D
-
May 23, 2019
1
2
3
...
23
Page 1 of 23
LATEST
Lung Cancer Among the Most Likely Conditions to Harm Patients who are Misdiagnosed
Peter Hofland, Ph.D
-
July 12, 2019
Japan Approves Olaparib as First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer
Peter Hofland, Ph.D
-
July 10, 2019
FDA Accepts Supplemental Biologics License Applications for Pembrolizumab
Peter Hofland, Ph.D
-
July 10, 2019
SNDX-5613 Shows Strong Tumor Growth Inhibition and Improved Survival in Preclinical Models –
Peter Hofland, Ph.D
-
July 10, 2019
US FDA to Review Isatuximab as a Potential Treatment for R/R Multiple Myeloma
Peter Hofland, Ph.D
-
July 10, 2019
